{"hands_on_practices": [{"introduction": "The fluorescence lifetime ($\\tau$) and quantum yield ($\\phi$) are cornerstone observables in spectroscopy, but they are not independent properties. They are both manifestations of the underlying kinetic competition between radiative ($k_r$) and non-radiative ($k_{nr}$) de-excitation pathways. This practice challenges you to dissect these relationships and infer changes in the fundamental rate constants from experimental data, a crucial skill for interpreting fluorescence-based biosensor and drug interaction studies. [@problem_id:1484190]", "problem": "A pharmaceutical research team is investigating the interaction between a novel fluorescent drug and a target protein. In the absence of the protein, the free drug molecule in an aqueous buffer solution exhibits a certain fluorescence quantum yield and fluorescence lifetime. When the drug binds to a specific pocket on the protein, its local chemical environment is altered. Time-resolved fluorescence spectroscopy experiments are conducted on both the free and protein-bound drug.\n\nThe experiments reveal two key changes upon binding:\n1. The fluorescence quantum yield of the protein-bound drug is 60% of the quantum yield of the free drug.\n2. The fluorescence lifetime of the protein-bound drug is 1.5 times the lifetime of the free drug.\n\nThe de-excitation of the drug's excited state can occur through two main pathways: radiative decay (fluorescence emission, with rate constant $k_r$) and non-radiative decay (with a combined rate constant $k_{nr}$). Based on the experimental findings, what is the consequence of binding on the drug's radiative decay rate constant, $k_r$?\n\nA. The radiative decay rate constant increases.\n\nB. The radiative decay rate constant decreases.\n\nC. The radiative decay rate constant remains the same.\n\nD. The radiative decay rate constant becomes zero.\n\nE. The change in the radiative decay rate constant cannot be determined from the information given.", "solution": "Let the free drug have quantum yield $\\phi_{f}$, lifetime $\\tau_{f}$, radiative rate $k_{r,f}$, and nonradiative rate $k_{nr,f}$. Let the bound drug have $\\phi_{b}$, $\\tau_{b}$, $k_{r,b}$, and $k_{nr,b}$. For a two-channel de-excitation (radiative and nonradiative), the standard relations are\n$$\n\\phi=\\frac{k_{r}}{k_{r}+k_{nr}},\\qquad \\tau=\\frac{1}{k_{r}+k_{nr}}.\n$$\nCombining these gives\n$$\n\\phi=k_{r}\\tau.\n$$\nApplying this to the free and bound cases,\n$$\n\\phi_{f}=k_{r,f}\\tau_{f},\\qquad \\phi_{b}=k_{r,b}\\tau_{b}.\n$$\nTaking the ratio,\n$$\n\\frac{\\phi_{b}}{\\phi_{f}}=\\frac{k_{r,b}\\tau_{b}}{k_{r,f}\\tau_{f}}=\\left(\\frac{k_{r,b}}{k_{r,f}}\\right)\\left(\\frac{\\tau_{b}}{\\tau_{f}}\\right).\n$$\nGiven $\\phi_{b}=\\frac{3}{5}\\phi_{f}$ and $\\tau_{b}=\\frac{3}{2}\\tau_{f}$, substitute to obtain\n$$\n\\frac{3}{5}=\\left(\\frac{k_{r,b}}{k_{r,f}}\\right)\\left(\\frac{3}{2}\\right)\\quad\\Longrightarrow\\quad \\frac{k_{r,b}}{k_{r,f}}=\\frac{\\frac{3}{5}}{\\frac{3}{2}}=\\frac{2}{5}<1.\n$$\nThus, the radiative decay rate constant decreases upon binding. The correct option is B.", "answer": "$$\\boxed{B}$$", "id": "1484190"}, {"introduction": "Beyond intrinsic properties, time-resolved fluorescence is a powerful tool for studying how a fluorophore interacts with its environment. This exercise delves into dynamic quenching, a process where collisions with another molecule (a quencher) provide an additional non-radiative decay pathway. By applying the Stern-Volmer equation, you will learn how to extract quantitative kinetic information, like the bimolecular quenching rate constant ($k_q$), directly from lifetime measurements. [@problem_id:1484236]", "problem": "A biochemist is studying a newly isolated fluorescent protein, \"LumiProt\". In a buffer solution, the protein exhibits a characteristic fluorescence lifetime of 10.0 ns. The biochemist suspects that a small molecule, \"Inhibitor-X\", can interact with LumiProt in its excited state. To test this hypothesis, a solution is prepared containing LumiProt and 0.10 M of Inhibitor-X. A time-resolved fluorescence measurement on this new solution reveals that the fluorescence lifetime of LumiProt has been reduced to 2.0 ns. Assuming this interaction follows a dynamic collisional process, calculate the bimolecular rate constant for the interaction between excited LumiProt and Inhibitor-X.\n\nExpress your answer in units of $\\text{M}^{-1}\\text{s}^{-1}$ and round to two significant figures.", "solution": "For dynamic (collisional) quenching, the fluorescence lifetime follows the Stern–Volmer relation\n$$\\frac{\\tau_{0}}{\\tau}=1+k_{q}\\tau_{0}[Q],$$\nwhich is equivalent to\n$$\\frac{1}{\\tau}=\\frac{1}{\\tau_{0}}+k_{q}[Q].$$\nSolving for the bimolecular rate constant gives\n$$k_{q}=\\frac{\\frac{\\tau_{0}}{\\tau}-1}{\\tau_{0}[Q]}=\\frac{\\frac{1}{\\tau}-\\frac{1}{\\tau_{0}}}{[Q]}.$$\n\nGiven $\\tau_{0}=10.0\\times 10^{-9}\\ \\text{s}$, $\\tau=2.0\\times 10^{-9}\\ \\text{s}$, and $[Q]=0.10\\ \\text{M}$, compute the ratio\n$$\\frac{\\tau_{0}}{\\tau}=\\frac{10.0}{2.0}=5.$$\nThen\n$$k_{q}=\\frac{5-1}{(10.0\\times 10^{-9}\\ \\text{s})(0.10\\ \\text{M})}=\\frac{4}{1.0\\times 10^{-9}\\ \\text{s}\\cdot \\text{M}}=4.0\\times 10^{9}\\ \\text{M}^{-1}\\text{s}^{-1}.$$\n\nRounding to two significant figures yields the same value.", "answer": "$$\\boxed{4.0\\times 10^{9}}$$", "id": "1484236"}, {"introduction": "One of the most elegant applications of fluorescence lifetime measurements is Förster Resonance Energy Transfer (FRET), a phenomenon often described as a \"spectroscopic ruler.\" FRET allows for the detection of molecular interactions and the measurement of distances on the nanometer scale by monitoring energy transfer from a donor fluorophore to an acceptor. This problem provides a hands-on calculation of FRET efficiency from lifetime data, demonstrating how this technique quantifies the proximity between two molecules. [@problem_id:1484235]", "problem": "An analytical chemist is studying the binding affinity between two proteins, \"Luminase\" and \"Quenchidin,\" using a luminescence-based assay. Luminase is a fluorescent protein (the donor), and Quenchidin is a protein that can act as a non-radiative acceptor. The experimental strategy relies on Förster Resonance Energy Transfer (FRET), a mechanism where energy is transferred from an excited donor to an acceptor.\n\nThe experiment is conducted in two stages. First, a solution containing only the Luminase protein is analyzed using time-resolved fluorescence spectroscopy. The average fluorescence lifetime of the donor in the absence of the acceptor, $\\tau_D$, is measured to be 4.0 ns.\n\nIn the second stage, an excess of Quenchidin protein is added to the solution, allowing it to bind to Luminase. The fluorescence lifetime measurement is repeated for Luminase in the presence of Quenchidin. This new lifetime, $\\tau_{DA}$, is found to be 1.0 ns. The decrease in lifetime is attributed to the FRET process providing an additional pathway for the excited Luminase to return to its ground state.\n\nBased on these experimental results, calculate the FRET efficiency, which represents the fraction of energy transfer events occurring for each donor excitation event. Express your answer as a decimal value rounded to two significant figures.", "solution": "The problem asks for the Förster Resonance Energy Transfer (FRET) efficiency, denoted by $E$, given the fluorescence lifetime of the donor molecule both in the absence and presence of an acceptor molecule.\n\nThe FRET efficiency can be calculated directly from these two lifetime measurements. The fluorescence lifetime of the donor in the absence of the acceptor is $\\tau_D$. When the acceptor is present and energy transfer can occur, it introduces a new, non-radiative decay pathway for the donor's excited state. This causes the observed fluorescence lifetime of the donor to decrease to a new value, $\\tau_{DA}$.\n\nThe efficiency $E$ is defined as the ratio of the rate of energy transfer to the sum of all donor decay rates (including energy transfer, fluorescence, and other non-radiative processes). This can be expressed in terms of the lifetimes as:\n$$E = 1 - \\frac{\\tau_{DA}}{\\tau_D}$$\nThis formula quantifies the fraction of donor de-excitations that occur via energy transfer to the acceptor.\n\nFrom the problem statement, we are given the following values:\nThe fluorescence lifetime of the donor (Luminase) alone: $\\tau_D = 4.0$ ns.\nThe fluorescence lifetime of the donor in the presence of the acceptor (Quenchidin): $\\tau_{DA} = 1.0$ ns.\n\nNow, we substitute these values into the efficiency equation:\n$$E = 1 - \\frac{1.0 \\, \\text{ns}}{4.0 \\, \\text{ns}}$$\nThe units of nanoseconds (ns) in the numerator and denominator cancel out, yielding a dimensionless value for the efficiency, as expected.\n$$E = 1 - \\frac{1.0}{4.0}$$\n$$E = 1 - 0.25$$\n$$E = 0.75$$\n\nThe problem requires the answer to be expressed as a decimal value rounded to two significant figures. Our calculated value, 0.75, is already in this format.", "answer": "$$\\boxed{0.75}$$", "id": "1484235"}]}